title: Serotonin toxicity in a CYP2D6 poor metabolizer, initially diagnosed as a drug-resistant major depression.
authors.forename: Florence
authors.initials: F
authors.lastname: Gressier
authors.forename: Pierre
authors.initials: P
authors.lastname: Ellul
authors.forename: Céline
authors.initials: C
authors.lastname: Dutech
authors.forename: Abd El Kader
authors.initials: AEK
authors.lastname: Ait Tayeb
authors.forename: Joel
authors.initials: J
authors.lastname: Monfort
authors.forename: Emmanuelle
authors.initials: E
authors.lastname: Corruble
authors.forename: Laurent
authors.initials: L
authors.lastname: Becquemont
authors.forename: Patrick
authors.initials: P
authors.lastname: Hardy
authors.forename: Céline
authors.initials: C
authors.lastname: Verstuyft
mesh_terms: D003511:Cyclohexanols / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics; D003692:Delayed-Action Preparations; D061218:Depressive Disorder, Treatment-Resistant / Q000175:diagnosis*; D005838:Genotype; D006801:Humans; D008297:Male; D008875:Middle Aged; D020230:Serotonin Syndrome / Q000139:chemically induced* / Q000235:genetics*; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D000069470:Venlafaxine Hydrochloride
chemical_list: D003511:Cyclohexanols; D019389:Cytochrome P-450 CYP2D6; D003692:Delayed-Action Preparations; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride